The facts about organ donationWalesOnlineSigning up to the organ donor register is a more permanent way of expressing what you want to do. Q: What if I registered years ago, lost my card and changed addresses. How do I check I'm still on the organ …
New Psoriasis Guidelines Expand Treatment Options – MedPage Today
New Psoriasis Guidelines Expand Treatment OptionsMedPage TodayPoint out that conventional drugs such as methotrexate and cyclosporine often are effective, but have significant toxicities, including liver problems with methotrexate and kidney problems w…
The Top Myeloma Beacon Patient And Caregiver Columns Of 2011 – The Myeloma Beacon
The Top Myeloma Beacon Patient And Caregiver Columns Of 2011The Myeloma BeaconMy Stem Cell Transplant – In another column, Dr. Goodman described the stem cell transplant process for patients who may be considering one. He also wrote about his persona…
A JOURNEY OF HOPE – Part II – The Sacramento Press
The Sacramento PressA JOURNEY OF HOPE – Part IIThe Sacramento PressOur intuitions were confirmed when the geneticist from the National Marrow Donor Program (“Be The Match”) compared Katie's HLA typing with gene pools around the world. Not surpr…
Nanotech transforms cyclosporine into safer transplant drug – FierceDrugDelivery
Nanotechnology NewsNanotech transforms cyclosporine into safer transplant drugFierceDrugDeliveryThe Times of India reports that researchers at the University of Strathclyde in Scotland are working on a nano-sized drug particle version of cyclosporine, …
FDA Approves Inlyta To Treat Patients With a Type of Advanced Kidney Cancer – Sacramento Bee
WANEFDA Approves Inlyta To Treat Patients With a Type of Advanced Kidney CancerSacramento BeeRecently approved drugs for the treatment of kidney cancer include sorafenib (2005), sunitinib (2006), temsirolimus (2007), everolimus (2009), bevacizumab (200…
Steroid-Sparing Renal Transplant Yields Successful Outcomes – Doctors Lounge
Steroid-Sparing Renal Transplant Yields Successful OutcomesDoctors LoungeAcute rejection rates were 31 and 25 percent, respectively, and chronic rejection due to interstitial fibrosis/tubular atrophy occurred in 47 and 39 percent of LD and DD recipient…
Q&A: What does Ontario's first cardiac stem cell transplant mean for Canadians? – Global Toronto
The Express TribuneQ&A: What does Ontario's first cardiac stem cell transplant mean for Canadians?Global TorontoToronto doctors have performed Ontario's first cardiac stem cell transplant using bone marrow cells of the patient in question. …
Sycamore Shoals Hospital receives certification for congestive heart failure … – Elizabethton Star
Sycamore Shoals Hospital receives certification for congestive heart failure …Elizabethton StarBy Ashley Rader Sycamore Shoals Hospital recently received the Joint Commission's Advanced Certification for congestive heart failure for its high-qual…
Regenerative medicine company encouraged by heart failure trial – MedCity News
Regenerative medicine company encouraged by heart failure trialMedCity NewsRegenerative medicine company Juventas Therapeutics is touting the results from 12-month data of a phase 1 clinical trial of heart failure patients. At 12 months, heart failure …